Research Article | Open Access
Rehab Bahy1 , Mona H. Hetta2, Mohamed N.F. Shaheen3 and Marwa S. Abu bakr4
1Faculty of Pharmacy, Microbiology and Immunology Department, Fayoum University, 63415, Fayoum, Egypt.
2Faculty of Pharmacy, Pharmacognosy Department, Fayoum University, 63415, Fayoum, Egypt.
3Environmental Virology Laboratory, Water Pollution Research Department, Environment and Climate Change Research Institute, National Research Center, 12622 Dokki, Giza, Egypt.
4Department of Pharmacognosy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
Article Number: 7935 | © The Author(s). 2022
J Pure Appl Microbiol. 2022;16(4):2688-2694.
Received: 24 June 2022 | Accepted: 08 October 2022 | Published online: 07 November 2022
Issue online: December 2022

The interest in many traditional natural products is increasing. Natural products continue producing bioactive agents owing to the remarkable available chemical diversity. They were evaluated as prospective therapeutic candidates for the treatment of human and animal infectious diseases. Euphorbiaceae, the spurge family, holds a significant place in the domain of plant families, with scientific evidence of antiviral, antibacterial, anticancer, cytotoxic and antitumor properties. In this regard, the current study intends to investigate the antibacterial, antifungal, antiviral and cytotoxic properties of Euphorbia greenwayi var. greenwayi Bally & S. Carter. The dried aerial parts of E. greenwayi var. greenwayi Bally & S. Carter were used, then extracted with 70% ethanol, solvent was distilled off till dryness. The antimicrobial activity of the extract and both MIC and MBC were evaluated against one strain of Gram-positive bacteria: Staphylococcus aureus ATCC9144; four strains of Gram-negative bacteria: Klebsiella pneumonia ATCC10031, Escherichia coli ATCC10536, Salmonella typhi ATCC14028, Pseudomonas aeruginosa ATCC9027and yeast: Candida albicans ATCC10231. The antiviral activity of hydroalcoholic extract against Rotavirus infection was determined as well as the cytotoxic properties. The antibacterial examination revealed potential activity of the hydroalcoholic extract against all tested species with the inhibition zone ranged from 14.7 to 29.7 mm. The highest activity was against S. aureus and C. albicans. MIC and MBC results proved that the extract is potentially bacteriostatic and bactericidal agents against both Gram-positive and Gram-negative bacteria and against the tested yeast. Also, the extract has the ability to prevent Rotavirus attachment with the cell host. This research revealed that the hydroalcoholic extract of aerial parts of E. greenwayi var. greenwayi Bally & S. Carter has significant antimicrobial potential that can be implemented in different pharmaceutical formulations.


E.greenwayi var. Greenwayi Bally & S. Carter, Antimicrobial Activity, Antiviral Activity, Plant Extract, Cytotoxicity


The ancient Egyptians utilized a variety of herbs in their medicines, which were clearly documented in their papyri.1 The Egyptian flora contains over 2185 species, which provide as a valuable source of medically important compounds.2

Medicinal plants are still one of the most important therapeutic tools in traditional medicine in Egypt, as they are in other developing countries. The Egyptian flora provides great opportunities for the identification of novel chemicals with a variety of therapeutic properties. Egyptian medicinal plant’s antibacterial activity has been reported on multiple occasions.3-5

The spurge family Euphorbiaceae is considered a large flowering family of plants with 300 genera and 5000 species; having milky poisonous juice. Euphorbia genus is one of the largest genera in the Egyptian flora and it is distributed in the Nile Delta and Upper Egypt6 with nearly 2000 species worldwide, 750 species in Africa where 42 species of them are in Egypt. Some species of Euphorbiaceae have been used in treatment of paralysis, dermatosis, and body pain; also, they have been used as a poultice for treatment of skin ulcerations. A number of biological activities have been approved recently ranging from antispasmodic, cytotoxic, anti-inflammatory, hepatoprotective, antibacterial, anti-mutagenic, antifungal and antiviral.7 E.greenwayivar.greenwayi Bally & S. Carter belongs to family Euphorbiaceae. It is a semi-perennial succulent plant. Its flowers are small, yellow in color and grow alongside the thorns.

The antimicrobial activity of Euphorbia species has been previously reported, beside the MIC values of different extracts,8-12 herein, it is the first report on the antimicrobial activity of ethanol extract of E.greenwayivar.greenwayi Bally & S. Carter on Gram-positive, Gram-negative bacteria and yeast, and to correlate the chemical components of this species with the biological activity in order to develop a new antimicrobial natural drugs.

Many Euphorbia species have been reported to have medicinal properties because of the presence the variety of phytochemicals such as terpenoids, flavonoids and polyphenols compounds, which exhibit a great variety of biological activities.13 Different studies revealed the presence of number of active constituents have been isolated from Euphorbia species. Afzelin, myricitrin, quercitrin, quercitin, rutin, 2,4,6-tri-O-galloyl-β-D-glucose,euphorbin-A, B, C, D, kaempferol, 1,3,4,6-tetra-O-galloyl-β-D-glucose, gallic acid, protocatechuic acid, 24-methylenecycloartenol, β-amyrin,β-sitosterol, nonacosane, heptacosane, shikimic acid, tinyatoxin, camphol, choline and derivatives of quercitol containing the rhamnose acid.14

Materials and Methods

Plant Extract
The plant was collected from Cactus farm in El Mansouria, Giza, Egypt. It was authenticated by Eng. Therase Labib, Senior botanist in El Orman Garden, Egypt. A voucher specimen no. (FUPD-60) was kept in Faculty of Pharmacy, Pharmacognosy Department; Fayoum University.

The aerial parts of E.greenwayivar. greenwayi Bally & S. Carter were used. They were cut into small pieces then air-dried and weighed. The dried powder was exhaustively extracted with 70% ethanol at room temperature. The solvent was distilled off using a rotary evaporator till dryness and kept for further studies.

Preparation of Sample for Biological Activity
A part of the dried hydroalcoholic extract was diluted in 5% Dimethyl sulfoxide (DMSO) to concentration of 50mg/ml and stored at 4°C.

Bacterial Strains
The antimicrobial activity of the hydroalcoholic extract of Euphorbia was evaluated against five bacterial strains: One strain of Gram-positive bacteria: Staphylococcus aureus ATCC9144; four strains of Gram-negative bacteria: Klebsiella pneumonia ATCC10031, Escherichia coli ATCC10536, Salmonella typhi ATCC14028, Pseudomonas aeruginosa ATCC9027and yeast: Candida albicans ATCC10231. All ATCC strains were provided from Microbiology and Immunology Department, Faculty of Pharmacy, Fayoum University.

Inoculums Preparation
Bacterial strains were sub-cultured at 37°C overnight in Mueller-Hilton (MH) agar slants. Next day the bacterial growth was harvested in 5 ml of sterile saline water; the viable cell count was adjusted to 107 CFU/ml of bacteria, 104 CFU/ml of yeast at 580 nm using spectrophotometer.

Antimicrobial Activity
Antimicrobial activity was determined using agar well diffusion method. A suspension of bacteria and yeast (100 μl)was inoculated into Mueller Hinton (MH) Agar (Difco) and into Sabouroud Dextrose Agar (Difco), respectively. The wells were prepared in the plates by cork-borer. The plant alcoholic extract(100 μl)was introduced into each well; thee replication for all the testing strains were used to test the activity of hydroalcoholic extract. Then the plates were incubated at 37°C, for 24 h for bacterial strains and at 25°C for 72 h for yeast. Inhibition zones against the tested species were measured to determine the antimicrobial activity.15

Determination of Minimum Inhibitory Concentrations (MIC) and Minimal Bactericidal Concentration (MBC)
Microdilution method was to determine the MIC of plant extract for S.aureus, K. pneumonia, E. coli, S.typhi, P.aeruginosa and C. albicans.16 Briefly, bacterial organisms were cultured in Muller Hinton broth, while sabaroud broth was used to culture C. albicans for 24 h at 37°C. The plant extract was diluted in 5% DMSO and adjusted at a concentration range from 50 to 0.39mg/ml of the original solution. One hundred µl of the extract (50 mg/ml) were added to the first wells of the microplate and then diluted two-fold serially down the wells with MH broth, one hundred µl of culture were added to the wells, extract free solvent and un-inoculated broth were used as blank, inoculated broth was used as positive control then, the plates were incubated for 24 h at 37°C. After incubation, 2 µl of tetrazolium chloride was added to evaluate microbial growth inhibition. The results were observed after 30 min. Clear wells with lowest concentration were considered as the MIC values. For MBC determination, all wells which did not show any visible signs of growth (MIC and higher concentrations), The MH agar plates were inoculated with loopful using the streak plate technique. The MBC of tested extract against tested species was determined to be the lowest concentration at which the tested organisms did not exhibit any signs of growth.17 Each test was run three times, and the findings were presented as means. ± SD.

Antiviral Activity against Rotavirus Infection
Cells and Virus
MA104 monkey kidney cells were purchased from VACSERA, simian rotavirus (RV) SA-11 stock was acquired from the National Institute for Cholera and Enteric Diseases (NICED), Department of Virology, Kolkata, India. In a humidified incubator with 5% CO2, Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS) was used to culture the cells, and 100 g/ml streptomycin and 100 units/ml penicillin (All purchased from Lonza, Belgium). Trypsin 10 mg/ml was used to pre-activate the Simian rotavirus SA-11 stock for 30 min at 37°C. After 72 hours of incubation, the cytopathic effect of the activated RV stock that had been diluted tenfold was assessed in MA 104 cells. The previously established Karber method (Finney, 1978) was used to determine the 50% tissue culture infectious doses/0.1 ml (TCID50/0.1ml), which were then stored in small aliquots, which can be stored at -80°C until utilized.

Cytotoxicity Evaluation
Evaluation of Cell morphology by using inverted light microscopy18 – MA104 cell lines (2×105 cells/ml) were seeded in tissue culture plates 96-well (Corning, US). After incubation for 24 h at 37°C in a humidified 5% CO2 atmosphere, the culture medium was discarded and replaced with 200 µl of compound dilutions (1000, 750, 500, 250, 125, 62.5 µg/ml) per well prepared in culture medium. For cell controls, adding 200 µl of culture medium without compounds. All plates completed a 72-hour incubation period at 37°C in a humidified environment containing 5% CO2. Daily checks were made for morphological changes that could be seen under a microscope, like cell rounding and shrinkage, loss of confluence, cytoplasm granulation, or vacuolization. The antiviral assay was chosen using dilutions that are 100% safe against the cell morphology after scoring the morphological modification.

Antiviral Activities of Compound using the Cytopathic Effect of Measurement
For TCID50 determination, dilution from each compound that is 100% safe was selected to evaluate its activity against RV infection. 10-fold dilution of activated RV SA-11 were achieved in cell culture medium then100 μl of viral dilutions 10-4–10-9 were incubated after addition of 100 μl of cell culture containing the tested compound for one hour incubation at 37°C in CO2 incubator. Virus dilutions either with tested compound or without it were inoculated into four parallel wells. All plates completed incubation period of 72h at 37°C in CO2 incubator, then, the inverted microscope was used to observe the cytopathic effect. Virus titration was calculated and then expressed as TCID50 (50% tissue culture infection dose) using Spearman-Karber method.19 Differences between the treated virus value and untreated virus were used in calculation of reduction in virus titer.


Antimicrobial Activity
Euphorbia extract was investigated to evaluate its activities against chosen strains of Gram-negative bacteria (K. pneumonia, E. coli, S. typhi and P. aeruginosa), Gram-positive bacteria (S. aureus) and yeast (C. albicans) using agar well diffusion method. Results of antibacterial activity revealed that hydroalcoholic extract of E.greenwayi var. greenwayi Bally & S. Carter was potentially active in suppressing microbial growth of all tested species and the inhibition zone ranged from 14.7 to 29.7 mm (Table 1). The most antimicrobial activity was against Gram-positive bacteria S. aureus (29.3 mm)as well as yeast C. albicans (29.7 mm), while effect against E. coli. (14.7mm) was the least one. Based on these results, the minimal inhibitory concentration (MIC) as well as the minimal bactericidal concentration (MBC) against chosen species were tested.

Table (1):
Results of antimicrobial activity.

Inhibition Zone (mm)
29.3 ± 0.57
17.7 ± 0.57
14.7 ± 0.57
S. typhi
27.7 ± 0.57
P. aeruginosa
19.7 ± 0.57
C. albicans
29.7± 0.57

*Results are means of three replicates (n = 3) ± standard deviation. * p-value was significant < 0.05.

MIC and MBC of Plant Extract
MIC value and MBC value of the plant hydroalcoholic extract were determined using broth Microdilution method to evaluate its bacteriostatic and bactericidal properties. Table 2 represent data (Table 2).

Table (2):
MIC and MBC Results.

MIC (mg/mL)
MBC (mg/mL)
S. aureus
K. pneumonia
E. coli
S. typhi
P. aeruginosa
C. albicans

MIC and MBC results showed that the hydroalcoholic extract is potentially active as bacteriostatic and bactericidal against both Gram-positive bacteria and Gram-negative bacteria beside its activity against the tested yeast.

Cytotoxicity and Antiviral Activity Evaluation
In this study, we used the microscopic examination in investigating the safe concentration of the tested extract. Results demonstrated that the 100% safe concentration of the tested extract was 750 µg/ml which showed 2.25 log10 TCID50/0.1 ml reduction effect in the virus titer as represented in Table 3.

Table (3):
Antiviral impact of extract on RV SA11 using TCID50 / 0.1 ml measurement.

Titers of viruses without compounds
Titers of viruses with compounds
Virus titer reduction value

Family Euphorbiaceae is used in Egyptian traditional medicine for treatment against infectious disease. This study focuses on testing the activity of the aerial parts of E.greenwayi var. greenwayi Bally & S. Carter as antimicrobial agent against Gram-positive, negative bacteria, yeast and viruses as the first report. This study revealed that the plant hydroalcoholic extract of this species showed antimicrobial impact against both Gram-positive bacteria (S. aureus) and Gram-negative bacteria (K. pneumonia, E. coli, S. typhi and P. aeruginosa) as well as yeast (C. albicans). Other Euphorbia species are reported for their great importance as antibacterial activity.20-24 The market prefers natural and healthy products with no synthetic raw materials because f their side effects, thus there is indeed a growing interest in natural antimicrobial agents. The one among the most and influential studies on this areas summarized by Salehi, Iriti, Vitalini, Antolak, Pawlikowska, Kregiel, Sharifi-Rad, Oyeleye, Ademiluyi, Czopek, Staniak, Custodio, Coy-Barrera, Segura-Carretero, Cadiz-Gurrea, Capasso, Cho, Seca13 illustrating wide range of antimicrobial activities for several Euphorbia species such as E. royleana Boiss, E. hirta L., E. tirucalli L., E. neriifolia L., E. paralias L, E. granulate Forssk, E. helioscopia L. and E. characias L.

The extraction technique used in this study was the same as reported by25,26; where, the ethanol extract of aerial part from E. hirta L. proved to prevent the growth of most types of bacteria and fungi in different studies.

Several Euphorbia spp. cultivated in Egypt are well known for their antimicrobial activity. A reported study demonstrated the antimicrobial activity against Bacillus subtilis of E.helioscopia which was attributed to the presence of the essential oil from the inflorescence.27 The methanol extract of wild Egyptian Sahara plant E. paralias was reported to be active against Mycobacterium spp.28 The biological activities of ethyl acetate and dichloromethane extracts of E.paralias and E. geniculate showed strong antibacterial effect.29 The ethanol extract of E. hirta L. exhibits high antibacterial activity against Streptococcus mutans obtained from samples of dental plaque isolated from patients suffering from dental caries.30

Since an effective medicine should not exhibit either chronic toxicity or chronic adverse effects on the host, cytotoxicity testing is an important stage in the evaluation of a possible antiviral drug. The studied extract should have no or minimal effects on cellular metabolism and be completely selective for particular viral activities.18 Since an effective medicine should not exhibit either chronic toxicity or chronic adverse effects on the host, cytotoxicity testing is an important stage in the evaluation of a possible antiviral drug. The studied extract should have no or minimal effects on cellular metabolism and be completely selective for viral activities.31

There are several stages in the viral life cycle, including 1) attachment, 2) penetration, 3) replication of viral proteins and genetic material, and 4) assembly and viral egress from infected cells. Anti-rotavirus medications can be used to combat these actions. SA-11 agents.32 Our findings showed that the extract under test may influence RV infections by interacting with viral capsid and inhibiting the virus from attaching to the cell host.

It is necessary to conduct additional research on the antiviral activity in cell culture to illustrate the mechanism of this extract which affects the virus replication by adapting other replication steps.


E.greenwayivar. greenwayi Bally & S. Carter aerial parts hydro alcoholic extract can be used in different pharmaceutical preparations as a natural antimicrobial agent.


The authors would like to thank all their colleagues and specially Prof. Mohamed Ahmed, who helped and facilitate in conducting experiments and making the laboratory experiments easier.

The authors declare that there is no conflict of interest.

All authors contributed to the study conceptualization and design. Material preparation, sample collection, laboratory experiments, first draft writing were performed by RB. Editing, reviewing and supervision were done by MHH and MSA. All authors read and approved the final manuscript for publication.


The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.

Not Applicable.

  1. Mostafa NM, Singab AN. Prospective of Herbal Medicine in Egypt. Medicinal Chemistry. 2018;8(4):116-117.
  2. Boulos L. Flora of Egypt. Cairo: Al Hadara. 2000;22.
  3. Al-Tohamy R, Ali SS, Saad-Allah K, et al. Phytochemical analysis and assessment of antioxidant and antimicrobial activities of some medicinal plant species from Egyptian flora. Journal of Applied Biomedicine. 2018;16(4):289-300.
  4. Elsharkawy ER, Ed-dra A, Alghanem S, Abdallah EM. Comparative Studies of Chemical Compostion, Antimicrobial and Antioxidant Activity of Essential Oil of Some Species from Genus Artemisia. Journal of Natural Remedies. 2018;18(1).
  5. Abdel-Hameed ES, El-Nahas HA, Abo-Sedera SA. Antischistosomal and Antimicrobial Activities of Some Egyptian Plant Species. Pharmaceutical Biology. 2008;46(9):626-633.
  6. Batanouny KH, Stichler W, Ziegler H. Photosynthetic pathways and ecological distribution of Euphorbia species in Egypt. Oecologia. 1991;87(4):565-569.
  7. Hegazy MF, Hamed AR, Ibrahim MAA, et al. Euphosantianane A(-)D: Antiproliferative Premyrsinane Diterpenoids from the Endemic Egyptian Plant Euphorbia Sanctae-Catharinae. Molecules. 2018;23(9).
  8. Kirbag S, Erecevit P, Zengin F, Guvenc AN. Antimicrobial activities of some Euphorbia species. Afr J Tradit Complement Altern Med. 2013;10(5):305-309.
  9. Sudhakar M, Rao Ch V, Rao PM, Raju DB, Venkateswarlu Y. Antimicrobial activity of Caesalpinia pulcherrima, Euphorbia hirta and Asystasia gangeticum. Fitoterapia. 2006;77(5):378-380.
  10. Annamalai A, Christina VL, Sudha D, Kalpana M, Lakshmi PT. Green synthesis, characterization and antimicrobial activity of Au NPs using Euphorbia hirta L. leaf extract. Colloids Surf B Biointerfaces. 2013;108:60-65.
  11. Gupta R, Gupta J. Investigation of antimicrobial activity of Euphorbia hirta leaves. International Journal of Life Science and Pharma Research. 2019;9(3):32-37.
  12. A Esmael, MG Hassan, MM Amer, et al. Antimicrobial activity of certain natural-based plant oils against the antibiotic-resistant acne bacteria. Saudi Journal of Biological Sciences, 2020; 27(1):448-455
  13. Salehi B, Iriti M, Vitalini S, et al. Euphorbia-Derived Natural Products with Potential for Use in Health Maintenance. Biomolecules. 2019;9(8):337.
  14. Kumar S, Malhotra R, Kumar D. Euphorbia hirta:its chemistry, traditional and medicinal uses and pharmacological activity. Pharmacogn Rev. 2010;4(7):58-61.
  15. Valgas C, De Souza SM, Smania EFA. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol. 2007;38:369-380.
  16. Eloff JN. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica 1998;64(8):711-713.
  17. Kahlmeter G, Brown DFJ, Goldstein BFW, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect. 2006;12(6):501-503.
  18. Simoes CM, Amoros M, Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phytother Res. 1999;13(4):323-328.
  19. Grimm H, FINNEY DJ. Statistical Method in Biological Assay. 3. ed. Charles Griffin & Co., London and High Wycombe 1978. VII, 508 S, £ 19 net. Biometrical Journal. 1979;21(7):689-690.
  20. Mali PY, Panchal SS. Euphorbia tirucalli L.: Review on morphology, medicinal uses, phytochemistry and pharmacological activities. Asian Pacific Journal of Tropical Biomedicine. 2017;7(7):603-613.
  21. Mali PY, Panchal SS. Euphorbia neriifolia L.: Review on botany, ethnomedicinal uses, phytochemistry and biological activities. Asian Pacific Journal of Tropical Medicine. 2017;10(5):430-438.
  22. Sharanappa R, Vidyasagar GM. Anti-Candida activity of medicinal plants. A Review. Int J Pharm Pharm Sci. 2013;5(4):9-16.
  23. Kone JK, Bello OO, Onifade AK. Antimicrobial potency of Euphorbia heterophylla against selected clinical isolates. The Proceedings of the Nigerian Academy of Science. 2020; 13(2).
  24. Kumari I. A study of the antimicrobial effect of Euphorbia hirta L. against Escherichia coli. Vegetos. 2018;31(3):123-125.
  25. Awaad AS, Alothman MR, Zain YM, Zain GM, Alqasoumi SI, Hassan DA. Comparative nutritional value and antimicrobial activities between three Euphorbia species growing in Saudi Arabia. Saudi Pharm J. 2017;25(8):1226-1230.
  26. Tran N, Nguyen M, Le KP, Nguyen N, Tran Q, Le L. Screening of Antibacterial Activity, Antioxidant Activity, and Anticancer Activity of Euphorbia hirta Linn. Extracts. Applied Sciences. 2020;10(23):8408.
  27. Beltagy A. Chemical comosition and antibacteriral activity of medically useful essential oil from the inflorescsnce of Euphorbia helioscopia L. growen in Egypt 2019. IJPSR. 2019;10:3648.
  28. Safwat NA, Kashef MT, Aziz RK, Amer KF, Ramadan MA. Quercetin 3-O-glucoside recovered from the wild Egyptian Sahara plant, Euphorbia paralias L., inhibits glutamine synthetase and has antimycobacterial activity. Tuberculosis. 2018;108:106-113
  29. Ghani A, Eltomyorcid S, Eldougdoug W, Badr W, Hassan H. New Acetyl Triterpenoidal and Biological Activities of Euphorbia Paralias and Euophorbia Geniculata (Euphorbiaceae) from Egypt. Egypt J Chem. 2020;63(10):3583-3595.
  30. Helmy MM, Bakr RO. In vitro Comparison of the Antimicrobial Activity of Five Herbal Extracts, and Selected Mouthwashes Marketed in Egypt against Cariogenic Streptococcus Mutans. The Egyptian Society of Medical Microbiology. 2014;23(1):49-58.
  31. Andrighetti-Frohner CR, Antonio RV, Creczynski-Pasa TB, Barardi CR, Simoes CM. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem Inst Oswaldo Cruz. 2003;98(6):843-848.
  32. Knipe DMFBN. Fields’ virology. Philadelphia: Lippincott Williams & Wilkins; 2007.

Article Metrics

Article View: 175

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.